Inventor
BRADBURY ROBERT HUGH
GB24 patents
⚠️ This page may combine multiple inventors who share the name “BRADBURY ROBERT HUGH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTRAZENECA AB
14 patentsUS6838464B2Jan 4, 2005
2,4-Di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineaoplastic agents
ASTRAZENECA AB183 citations96
US6649608B2Nov 18, 2003
2,4-di(hetero-)arylamino (oxy)-5-substituted pyrimidines as antineoplastic agents
ASTRAZENECA AB68 citations94
US7148230B2Dec 12, 2006
Quinazoline derivatives
ASTRAZENECA AB42 citations92
US7067522B2Jun 27, 2006
2,4,DI (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents
ASTRAZENECA AB40 citations90
US9944650B2Apr 17, 2018
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases
ASTRAZENECA AB5 citations81
US9155727B2Oct 13, 2015
Chemical compounds
ASTRAZENECA AB5 citations79
US10766905B2Sep 8, 2020
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases
ASTRAZENECA AB1 citations70
US10407432B2Sep 10, 2019
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative diseases
ASTRAZENECA AB3 citations70
US7625908B2Dec 1, 2009
Quinazoline derivatives
ASTRAZENECA AB4 citations62
US8003649B2Aug 23, 2011
Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155
ASTRAZENECA AB4 citations61
US11407755B2Aug 9, 2022
[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases
ASTRAZENECA AB0 citations59
US10130617B2Nov 20, 2018
Chemical compounds
ASTRAZENECA AB0 citations46
US9616050B2Apr 11, 2017
Chemical compounds
ASTRAZENECA AB0 citations46
US7820683B2Oct 26, 2010
4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB receptor tyrosine kinase inhibitors for the treatment of cancer
ASTRAZENECA AB0 citations39
ZENECA LTD
7 patentsUS6083951AJul 4, 2000
Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists
ZENECA LTD50 citations96
US6060475AMay 9, 2000
Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof
ZENECA LTD21 citations92
US5866568AFeb 2, 1999
Heterocyclic compounds
ZENECA LTD23 citations92
US5861401AJan 19, 1999
N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
ZENECA LTD24 citations92
US5641793AJun 24, 1997
Pyridine compounds which have useful pharmaceutical activity
ZENECA LTD22 citations92
US5668137ASep 16, 1997
N-heterocyclic sulfonamides having endothelin receptor activity
ZENECA LTD24 citations86
US6258817B1Jul 10, 2001
Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereof
ZENECA LTD4 citations62